Population pharmacokinetics and Bayesian dose adjustment to advance TDM of anti-TB drugs
MGG Sturkenboom, AG Märtson, EM Svensson… - Clinical …, 2021 - Springer
Tuberculosis (TB) is still the number one cause of death due to an infectious disease.
Pharmacokinetics and pharmacodynamics of anti-TB drugs are key in the optimization of TB …
Pharmacokinetics and pharmacodynamics of anti-TB drugs are key in the optimization of TB …
[HTML][HTML] Tuberculosis of the spine
W Leowattana, P Leowattana… - World Journal of …, 2023 - ncbi.nlm.nih.gov
Pott's spine, commonly known as spinal tuberculosis (TB), is an extrapulmonary form of TB
caused by Mycobacterium TB. Pott's paraplegia occurs when the spine is involved. Spinal …
caused by Mycobacterium TB. Pott's paraplegia occurs when the spine is involved. Spinal …
Therapeutic drug monitoring in patients with tuberculosis and concurrent medical problems
AG Märtson, G Burch, S Ghimire… - Expert Opinion on …, 2021 - Taylor & Francis
Introduction Therapeutic drug monitoring (TDM) has been recommended for treatment
optimization in tuberculosis (TB) but is only is used in certain countries eg USA, Germany …
optimization in tuberculosis (TB) but is only is used in certain countries eg USA, Germany …
Population pharmacokinetics of linezolid in tuberculosis patients: dosing regimen simulation and target attainment analysis
The prolonged treatment duration for multidrug-resistant tuberculosis (MDR-TB) makes
linezolid dosing difficult because of adverse effects associated with long-term use. We …
linezolid dosing difficult because of adverse effects associated with long-term use. We …
Profiling cell envelope-antibiotic interactions reveals vulnerabilities to β-lactams in a multidrug-resistant bacterium
The cell envelope of Gram-negative bacteria belonging to the Burkholderia cepacia complex
(Bcc) presents unique restrictions to antibiotic penetration. As a consequence, Bcc species …
(Bcc) presents unique restrictions to antibiotic penetration. As a consequence, Bcc species …
[HTML][HTML] Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis
Background Cycloserine, or its structural analogue terizidone, has been associated with
neuropsychiatric toxicity (psychosis, depression, and neuropathy). Prospective clinical data …
neuropsychiatric toxicity (psychosis, depression, and neuropathy). Prospective clinical data …
Population Pharmacokinetics and Dose Evaluation of Cycloserine among Patients with Multidrug-Resistant Tuberculosis under Standardized Treatment Regimens
Y Zhu, L Zhu, L Davies Forsman, J Paues… - Antimicrobial Agents …, 2023 - Am Soc Microbiol
Although cycloserine is a recommended drug for the treatment of multidrug-resistant
tuberculosis (MDR-TB) according to World Health Organization (WHO), few studies have …
tuberculosis (MDR-TB) according to World Health Organization (WHO), few studies have …
Acyldepsipeptide analogues: a future generation antibiotics for tuberculosis treatment
Acyldepsipeptides (ADEPs) are a new class of emerging antimicrobial peptides (AMPs),
which are currently explored for treatment of pathogenic infections, including tuberculosis …
which are currently explored for treatment of pathogenic infections, including tuberculosis …
[HTML][HTML] Second-line antituberculosis drug exposure thresholds predictive of adverse events in multidrug-resistant tuberculosis treatment
S Wang, LD Forsman, C Xu, H Zhang, Y Zhu… - International Journal of …, 2024 - Elsevier
Objectives This study aimed to investigate the association between drug exposure and
adverse events (AEs) during the standardized multidrug-resistant tuberculosis (MDR-TB) …
adverse events (AEs) during the standardized multidrug-resistant tuberculosis (MDR-TB) …
Therapeutic drug monitoring in tuberculosis
M Sarkar, J Sarkar - European Journal of Clinical Pharmacology, 2024 - Springer
Purpose Therapeutic drug monitoring (TDM) is a standard clinical procedure that uses the
pharmacokinetic and pharmacodynamic parameters of the drug in the body to determine the …
pharmacokinetic and pharmacodynamic parameters of the drug in the body to determine the …